Cargando…
HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
Vulvar lichen sclerosis (VLS) is a dermatologic disorder that affects women worldwide. Women with VLS have white, atrophic papules on the vulva. They suffer from life-long intense pruritus. Corticosteroids are the first-line of treatments and the most effective medicines for VLS. Although VLS has be...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321666/ https://www.ncbi.nlm.nih.gov/pubmed/34145025 http://dx.doi.org/10.26508/lsa.202000906 |
_version_ | 1783730899481788416 |
---|---|
author | Cong, Qing Guo, Xiao Zhang, Shengwei Wang, Jinhui Zhu, Yi Wang, Lili Lu, Guangxing Zhang, Yufeng Fu, Wei Zhou, Liying Wang, Shuaikang Liu, Cenxi Song, Jia Yang, Chaoyong Luo, Chi Ni, Ting Sui, Long Huang, He Li, Jin |
author_facet | Cong, Qing Guo, Xiao Zhang, Shengwei Wang, Jinhui Zhu, Yi Wang, Lili Lu, Guangxing Zhang, Yufeng Fu, Wei Zhou, Liying Wang, Shuaikang Liu, Cenxi Song, Jia Yang, Chaoyong Luo, Chi Ni, Ting Sui, Long Huang, He Li, Jin |
author_sort | Cong, Qing |
collection | PubMed |
description | Vulvar lichen sclerosis (VLS) is a dermatologic disorder that affects women worldwide. Women with VLS have white, atrophic papules on the vulva. They suffer from life-long intense pruritus. Corticosteroids are the first-line of treatments and the most effective medicines for VLS. Although VLS has been speculated as an autoimmune disease for a long time, its pathogenesis and the molecular mechanism is largely unknown. We performed a comprehensive multi-omics analysis of paired samples from VLS patients as well as healthy donors. From the RNA-seq analysis, we found that VLS is correlated to abnormal antivirus response because of the presence of Hepatitis C Virus poly U/UC sequences. Lipidomic and metabolomic analysis revealed that inflammation-induced metabolic disorders of fatty acids and glutathione were likely the reasons for pruritus, atrophy, and pigment loss in the vulva. Thus, the present study provides an initial interpretation of the pathogenesis and molecular mechanism of VLS and suggests that metabolic disorders that affect the vulva may serve as therapeutic targets for VLS. |
format | Online Article Text |
id | pubmed-8321666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-83216662021-08-04 HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis Cong, Qing Guo, Xiao Zhang, Shengwei Wang, Jinhui Zhu, Yi Wang, Lili Lu, Guangxing Zhang, Yufeng Fu, Wei Zhou, Liying Wang, Shuaikang Liu, Cenxi Song, Jia Yang, Chaoyong Luo, Chi Ni, Ting Sui, Long Huang, He Li, Jin Life Sci Alliance Research Articles Vulvar lichen sclerosis (VLS) is a dermatologic disorder that affects women worldwide. Women with VLS have white, atrophic papules on the vulva. They suffer from life-long intense pruritus. Corticosteroids are the first-line of treatments and the most effective medicines for VLS. Although VLS has been speculated as an autoimmune disease for a long time, its pathogenesis and the molecular mechanism is largely unknown. We performed a comprehensive multi-omics analysis of paired samples from VLS patients as well as healthy donors. From the RNA-seq analysis, we found that VLS is correlated to abnormal antivirus response because of the presence of Hepatitis C Virus poly U/UC sequences. Lipidomic and metabolomic analysis revealed that inflammation-induced metabolic disorders of fatty acids and glutathione were likely the reasons for pruritus, atrophy, and pigment loss in the vulva. Thus, the present study provides an initial interpretation of the pathogenesis and molecular mechanism of VLS and suggests that metabolic disorders that affect the vulva may serve as therapeutic targets for VLS. Life Science Alliance LLC 2021-06-18 /pmc/articles/PMC8321666/ /pubmed/34145025 http://dx.doi.org/10.26508/lsa.202000906 Text en © 2021 Cong et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Articles Cong, Qing Guo, Xiao Zhang, Shengwei Wang, Jinhui Zhu, Yi Wang, Lili Lu, Guangxing Zhang, Yufeng Fu, Wei Zhou, Liying Wang, Shuaikang Liu, Cenxi Song, Jia Yang, Chaoyong Luo, Chi Ni, Ting Sui, Long Huang, He Li, Jin HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
title | HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
title_full | HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
title_fullStr | HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
title_full_unstemmed | HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
title_short | HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
title_sort | hcv poly u/uc sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321666/ https://www.ncbi.nlm.nih.gov/pubmed/34145025 http://dx.doi.org/10.26508/lsa.202000906 |
work_keys_str_mv | AT congqing hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT guoxiao hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT zhangshengwei hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT wangjinhui hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT zhuyi hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT wanglili hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT luguangxing hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT zhangyufeng hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT fuwei hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT zhouliying hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT wangshuaikang hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT liucenxi hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT songjia hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT yangchaoyong hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT luochi hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT niting hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT suilong hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT huanghe hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis AT lijin hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis |